@newsramp.comQuantum BioPharma receives FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class drug designed to rebuild the myelin sheath in MS patients — a historic milestone in neurological therapeutics. #MultipleSclerosis #Biotech
@newsramp.comQuantum BioPharma (NASDAQ: QNTM) receives FDA IND clearance and advances Lucid-MS into a Phase 2 trial for multiple sclerosis. The first-in-class PAD2 inhibitor targets demyelination directly, not immune suppression. #MultipleSclerosis #Biopharma
@msnewstoday.bsky.socialDiscover more: https://bit.ly/46AWMLj
Columnist Ben Hofmeister chose to climb many ladders in his life and career, but navigating MS is a challenge he never wanted to face.
@abudd.bsky.social
@gregoryai.bsky.socialSphingosine-1-phosphate (S1P) receptor modulators are a class of therapeutic agents used for the treatment of multiple sclerosis (MS). There are four S1P modulators currently approved by the Food and Drug Administration/European Medical ...
#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #MedSky
@msnewstoday.bsky.socialTake a closer look: https://bit.ly/3UAH1RN
A new study suggests multiple sclerosis may be marked by problems with the body's ability to make new mitochondria, the powerhouses of cells.
@msnewstoday.bsky.socialDiscover more: https://bit.ly/4dc4GOH
In life with chronic illness, love doesn't mean pretending things are easy. It's silent work, says guest columnist Donald Kushner, MD.
@morethanms.bsky.socialToday’s profound observation about life with MS:
I got nothing, man.
Working on my website. Thinking about tattoos. Watching the world. Living my life.
Sometimes MS is the lens. Sometimes life is just life.
#MultipleSclerosis #MSLife #Disability #LifeWithMS #NotesFromAChangedLife
@disabilitybooks.bsky.socialWe've added new titles to our young adult's Bookshelf that deal with Multiple Sclerosis. For more information see www.disabilitybookshelf.com/physical-and... #booksondisability #disabilitywriters #DisabilityBookshelf #multiplesclerosis @annaksortino.bsky.social #booksky #invisible-disabilities
@gregoryai.bsky.socialNew clinical trial
Simulator-Based Assessment of Driving Performance in Patients With Parkinson's Disease and Multiple Sclerosis
@newsramp.comQuantum BioPharma (NASDAQ: QNTM) secures FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class drug designed to protect and repair the myelin sheath in multiple sclerosis patients — earning a new Wall Street buy rating. #Biotech #MultipleSclerosis
@ijmsc.bsky.socialBlack people with MS reported lower fatigue and depression and higher mental HRQOL than White people after controlling for covariates. Study authors note cultural resilience and social support may serve as protective factors.
www.ijmsc.org/view/symptom...
#MultipleSclerosis #QOL #MentalHealth
@reenie.bsky.socialHad a terrible nights sleep, decided to sleep in and woke up with a massive headache and stuffy nose.
I am really getting tired of feeling unwell and catching colds & viruses every time I try to be human.
Being immunocompromised suuuucks.
@abudd.bsky.social@gregoryai.bsky.socialJ Control Release. 2026 Sep 8:115339. doi: 10.1016/j.jconrel.2026.115339. Online ahead of print. ABSTRACT Chronic autoinflammatory diseases such as rheumatoid arthritis and multiple sclerosis lack curative therapies, and current immunosu...
#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #MedSky
@gregoryai.bsky.socialIn multiple sclerosis (MS), spontaneous remyelination occurs in early disease; however, this process becomes inefficient over time, resulting in sustained neurodegeneration and clinical deterioration. It is known that global tumor necros...
#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #MedSky
@disabilitybooks.bsky.socialWe've added new titles to our Bookshelf that deal with Multiple Sclerosis. For more information see www.disabilitybookshelf.com/physical-dis...
#booksondisability #disabilitywriters #DisabilityBookshelf #multiplesclerosis @playwrightsteve.bsky.social #disability #booksky
@msnewstoday.bsky.socialDiscover more: https://bit.ly/4xdIDhO
People with MS who report sleeping poorly tend to have a slower flow of waste through the glymphatic system, which acts as the brain's sewers.
@msnewstoday.bsky.socialDiscover more: https://bit.ly/46LAA0L
People with relapsing-remitting MS may have less diverse gut bacteria, with shifts in genes involved in virulence, per a study.